Peapack Gladstone Financial Corp / TMO
Peapack Gladstone Financial Corp’s Thermo Fisher Scientific Inc Position
Does Peapack Gladstone Financial Corp own Thermo Fisher Scientific Inc (TMO)? Yes — 49.7K shares worth $24M (+0.31% of its 13F portfolio) as of Q1 2026, down from 51.8K shares the prior filed quarter.
Position Value
$24M
Q1 2026
Shares
49.7K
% of Portfolio
+0.31%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 49.7K | $24M | +0.31% |
| Q4 2025 | 51.8K | $30M | +0.38% |
| Q3 2025 | 52.7K | $26M | +0.33% |
| Q2 2025 | 56.1K | $23M | +0.32% |
| Q1 2025 | 60.1K | $30M | +0.44% |
| Q4 2024 | 61.0K | $32M | +0.46% |
| Q3 2024 | 61.4K | $38M | +0.55% |
| Q2 2024 | 62.6K | $35M | +0.53% |
| Q1 2024 | 63.3K | $37M | +0.58% |
| Q4 2023 | 63.6K | $34M | +0.57% |
| Q3 2023 | 63.9K | $32M | +0.60% |
| Q2 2023 | 62.0K | $32M | +0.58% |
| Q1 2023 | 64.9K | $37M | +0.71% |
| Q4 2022 | 65.2K | $36M | +0.71% |
| Q3 2022 | 69.6K | $35M | +0.72% |
| Q2 2022 | 66.3K | $36M | +0.82% |
| Q1 2022 | 67.0K | $40M | +0.78% |
| Q4 2021 | 67.2K | $45M | +0.85% |
| Q3 2021 | 66.9K | $38M | +0.79% |
| Q2 2021 | 31.8K | $16M | +0.38% |
| Q1 2021 | 31.4K | $14M | +0.37% |
| Q4 2020 | 29.8K | $14M | +0.41% |
| Q3 2020 | 29.5K | $13M | +0.47% |
| Q2 2020 | 27.5K | $10M | +0.39% |
| Q1 2020 | 30.1K | $9M | +0.40% |
| Q4 2019 | 19.2K | $6M | +0.25% |
| Q3 2019 | 19.1K | $6M | +0.24% |
| Q2 2019 | 18.6K | $5M | +0.24% |
| Q1 2019 | 17.8K | $5M | +0.22% |
| Q4 2018 | 16.0K | $4M | +0.18% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of TMO.